ID24654A - Formulasi farmasi omeprazola - Google Patents

Formulasi farmasi omeprazola

Info

Publication number
ID24654A
ID24654A IDW991448A ID991448A ID24654A ID 24654 A ID24654 A ID 24654A ID W991448 A IDW991448 A ID W991448A ID 991448 A ID991448 A ID 991448A ID 24654 A ID24654 A ID 24654A
Authority
ID
Indonesia
Prior art keywords
omeprazola
pharmaceutical formulation
formulation
pharmaceutical
omeprazola pharmaceutical
Prior art date
Application number
IDW991448A
Other languages
English (en)
Indonesian (id)
Inventor
Magnus Erickson
Lars Josefsson
Original Assignee
Astra Aktibolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407122&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID24654(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktibolag filed Critical Astra Aktibolag
Publication of ID24654A publication Critical patent/ID24654A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IDW991448A 1997-05-28 1998-05-18 Formulasi farmasi omeprazola ID24654A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702000A SE9702000D0 (sv) 1997-05-28 1997-05-28 New pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ID24654A true ID24654A (id) 2000-07-27

Family

ID=20407122

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991448A ID24654A (id) 1997-05-28 1998-05-18 Formulasi farmasi omeprazola

Country Status (41)

Country Link
US (1) US6090827A (fr)
EP (1) EP0984773B1 (fr)
JP (1) JP4649001B2 (fr)
KR (1) KR100540721B1 (fr)
CN (1) CN1123338C (fr)
AR (1) AR012698A1 (fr)
AT (1) ATE234078T1 (fr)
AU (1) AU722879B2 (fr)
BR (1) BR9809484A (fr)
CA (1) CA2290531C (fr)
CZ (1) CZ298972B6 (fr)
DE (1) DE69812089T2 (fr)
DK (1) DK0984773T3 (fr)
DZ (1) DZ2494A1 (fr)
EE (1) EE03903B1 (fr)
EG (1) EG24044A (fr)
ES (1) ES2195342T3 (fr)
HK (1) HK1025744A1 (fr)
HR (1) HRP980260B1 (fr)
HU (1) HU229154B1 (fr)
ID (1) ID24654A (fr)
IL (1) IL132895A0 (fr)
IS (1) IS2856B (fr)
MA (1) MA26497A1 (fr)
MY (1) MY122298A (fr)
NO (1) NO328100B1 (fr)
NZ (1) NZ500886A (fr)
PL (1) PL194634B1 (fr)
PT (1) PT984773E (fr)
RS (1) RS49629B (fr)
RU (1) RU2207121C2 (fr)
SA (1) SA98190304B1 (fr)
SE (1) SE9702000D0 (fr)
SI (1) SI0984773T1 (fr)
SK (1) SK286625B6 (fr)
TN (1) TNSN98068A1 (fr)
TR (1) TR199902890T2 (fr)
TW (1) TW575435B (fr)
UA (1) UA71541C2 (fr)
WO (1) WO1998053803A1 (fr)
ZA (1) ZA984178B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6174548B1 (en) * 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
ES2373864T3 (es) * 1998-04-20 2012-02-09 Eisai R&D Management Co., Ltd. Composición estabilizada que contiene un compuesto de tipo bencimidazol.
SE9803772D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Pharmaceutical formulation
SE9902386D0 (sv) * 1999-06-22 1999-06-22 Astra Ab New formulation
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
ES2168043B1 (es) 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
KR20020038759A (ko) 1999-10-20 2002-05-23 다니구치 미즈오 벤즈이미다졸계 화합물 안정화 방법
US20040092511A1 (en) * 1999-12-10 2004-05-13 Billstein Stephan Anthony Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
JP2002234842A (ja) * 2001-02-09 2002-08-23 Kyowa Yakuhin Kogyo Kk 内服腸溶性製剤
EP1469839A2 (fr) * 2002-01-25 2004-10-27 Santarus, Inc. Administration par voie muqueuse d'inhibiteurs de la pompe a protons
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
FR2843121B3 (fr) 2002-08-02 2004-09-10 Rhodia Chimie Sa Agent ignifugeant, procede de preparation et l'utilisation de cet agent
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation
UA86015C2 (ru) * 2003-01-29 2009-03-25 Такеда Фармасьютикал Компани Лимитед Способ получения твердой лекарственной формы с покрытием
JP4567340B2 (ja) * 2003-01-29 2010-10-20 武田薬品工業株式会社 被覆製剤の製造方法
BRPI0407074A (pt) 2003-01-29 2006-01-24 Takeda Pharmaceutical Método para produção de uma preparação revestida, preparação revestida, e, método para melhorar a dissolução do cloridreto de pioglitazona de uma preparação revestida com cloridreto de pioglitazona
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
CN1311824C (zh) * 2004-04-21 2007-04-25 常州市第四制药厂有限公司 奥美拉唑肠溶微粒制剂及制备方法
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2324354T3 (es) * 2005-07-29 2009-08-05 Rottapharm S.P.A. Combinacion terapeutica de itriglumida e inhibidores de la bomba de protones en el tratamiento de trastornos gastrointestinales y relacionados.
AU2007266574A1 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
KR101436516B1 (ko) * 2007-07-23 2014-09-02 주식회사태평양제약 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법
WO2009041765A1 (fr) * 2007-09-28 2009-04-02 Ctc Bio, Inc. Composition pharmaceutique contenant de l'ésoméprazole
US8753680B2 (en) * 2008-03-28 2014-06-17 Ferrer Internacional S.A. Capsule for the prevention of cardiovascular diseases
MX2011001341A (es) 2008-08-19 2011-03-29 Xenoport Inc Prodrogas de metil hidrogeno fumarato, sus composiciones farmaceuticas, y metodos de uso.
US20140348915A9 (en) 2012-08-22 2014-11-27 Xenoport, Inc. Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
JP2015527372A (ja) 2012-08-22 2015-09-17 ゼノポート，インコーポレイティド 副作用を低減させるモノメチルフマレートおよびそのプロドラッグの投与方法
CN102961356A (zh) * 2012-12-11 2013-03-13 山西云鹏制药有限公司 一种含奥美拉唑的蓝色肠溶片剂的制备方法
WO2014160633A1 (fr) 2013-03-24 2014-10-02 Xenoport, Inc. Compositions pharmaceutiques de fumarate de diméthyle
US9416096B2 (en) 2013-09-06 2016-08-16 Xenoport, Inc. Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use
WO2015042294A1 (fr) * 2013-09-18 2015-03-26 Xenoport, Inc. Compositions de nanoparticules de fumarate de diméthyle
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2016174664A1 (fr) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Compositions à désintégration par voie orale
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US20230058473A1 (en) 2020-01-27 2023-02-23 Towa Pharmaceutical Co., Ltd. Esomeprazole oral preparation and method for producing the same
KR102432084B1 (ko) 2021-11-16 2022-08-12 알리코제약(주) S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제
WO2024075017A1 (fr) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition de calcification de valve aortique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH05255088A (ja) * 1991-11-05 1993-10-05 Yoshitomi Pharmaceut Ind Ltd 抗潰瘍剤含有製剤
JP2669446B2 (ja) * 1992-03-23 1997-10-27 信越化学工業株式会社 医薬品コーティング液用原料粉粒体
JPH0733659A (ja) * 1992-07-17 1995-02-03 Yoshitomi Pharmaceut Ind Ltd 抗潰瘍剤含有製剤
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
US5817338A (en) * 1994-07-08 1998-10-06 Astra Aktiebolag Multiple unit tableted dosage form of omeprazole
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms

Also Published As

Publication number Publication date
SA98190304B1 (ar) 2006-10-11
JP2002500665A (ja) 2002-01-08
HUP0002182A3 (en) 2003-02-28
SI0984773T1 (en) 2003-10-31
MA26497A1 (fr) 2004-12-20
DK0984773T3 (da) 2003-07-07
HU229154B1 (en) 2013-09-30
HUP0002182A2 (hu) 2002-05-29
CZ420299A3 (cs) 2000-05-17
PL194634B1 (pl) 2007-06-29
TNSN98068A1 (fr) 2005-03-15
AR012698A1 (es) 2000-11-08
EP0984773A1 (fr) 2000-03-15
CA2290531A1 (fr) 1998-12-03
IL132895A0 (en) 2001-03-19
DE69812089T2 (de) 2004-03-04
NO995809D0 (no) 1999-11-26
AU722879B2 (en) 2000-08-10
TW575435B (en) 2004-02-11
HRP980260B1 (en) 2003-10-31
RS49629B (sr) 2007-08-03
KR20010013104A (ko) 2001-02-26
YU60899A (sh) 2002-06-19
SK159099A3 (en) 2000-06-12
EE9900540A (et) 2000-06-15
CN1258217A (zh) 2000-06-28
HRP980260A2 (en) 1999-02-28
CA2290531C (fr) 2006-12-12
CN1123338C (zh) 2003-10-08
SE9702000D0 (sv) 1997-05-28
UA71541C2 (uk) 2004-12-15
PL337237A1 (en) 2000-08-14
SK286625B6 (sk) 2009-02-05
EP0984773B1 (fr) 2003-03-12
DZ2494A1 (fr) 2003-01-25
CZ298972B6 (cs) 2008-03-26
TR199902890T2 (xx) 2000-02-21
MY122298A (en) 2006-04-29
EE03903B1 (et) 2002-12-16
ZA984178B (en) 1998-11-30
IS2856B (is) 2013-11-15
NO995809L (no) 2000-01-28
RU2207121C2 (ru) 2003-06-27
IS5245A (is) 1999-11-11
JP4649001B2 (ja) 2011-03-09
AU7680398A (en) 1998-12-30
ES2195342T3 (es) 2003-12-01
US6090827A (en) 2000-07-18
EG24044A (en) 2008-04-13
HK1025744A1 (en) 2000-11-24
WO1998053803A1 (fr) 1998-12-03
NO328100B1 (no) 2009-12-07
BR9809484A (pt) 2000-06-20
ATE234078T1 (de) 2003-03-15
NZ500886A (en) 2001-11-30
DE69812089D1 (de) 2003-04-17
KR100540721B1 (ko) 2006-01-10
PT984773E (pt) 2003-07-31

Similar Documents

Publication Publication Date Title
ID24654A (id) Formulasi farmasi omeprazola
NO20001631L (no) 2-metyl-tieno-benzodiazepin formulering
DE69525148T2 (de) Pharmazeutische formulierung
NO20012915L (no) Ny farmasöytisk formulering
ID23874A (id) Obat
ID23299A (id) Formulasi-formulasi farmasi
BR9611367A (pt) Formulação farmacêutic liofilizada estável
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
DK1073417T3 (da) Farmaceutisk aerosolformulering
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
NO980546D0 (no) Farmasöytiske midler
NO981008D0 (no) Farmasöytisk formulering
ID16781A (id) Formulasi-formulasi farmasi
ID29294A (id) Komposisi farmasi
ID30032A (id) Formulasi farmasi
ITMI941169A0 (it) Formulazioni farmaceutiche
ID25857A (id) Komposisi farmasi
FI973230A (fi) Uusi farmaseuttinen formulaatio
ID23531A (id) Komposisi farmasi
SE9600141D0 (sv) Pharmaceutical formulation
SE9803952D0 (sv) Pharmaceutical formulation
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
BR1100755A (pt) composição farmacêutica
SE9404195D0 (sv) New pharmaceutical formulation